New combo attack on tough liver cancer shows promise in early trial

NCT ID NCT07122089

Recruiting now Disease control Sponsor: Center Eugene Marquis Source: ClinicalTrials.gov ↗

First seen May 07, 2026 · Last updated May 08, 2026 · Updated 1 time

Summary

This study tests a two-step treatment for people with advanced liver cancer that has spread into a major liver blood vessel. First, tiny radioactive beads are placed in the liver to shrink the tumor from inside. Then, two immunotherapy drugs are given to help the immune system fight any remaining cancer. The goal is to see if this combination shrinks tumors more effectively than current treatments.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA NON-RESECTABLE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

CHU de Grenoble
ACTIVE_NOT_RECRUITING

Grenoble, France
CHU de Lille
ACTIVE_NOT_RECRUITING

Lille, France
CHU de Montpellier
ACTIVE_NOT_RECRUITING

Montpellier, France
CHU de Nice
ACTIVE_NOT_RECRUITING

Nice, France
Centre Eugène Marquis
RECRUITING

Rennes, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
La Timone
NOT_YET_RECRUITING

Marseille, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

HEPATOCELLULAR CARCINOMA NON-RESECTABLE